Preparation and characterization of bupivacaine multivesicular liposome: A QbD study about the effects of formulation and process on critical quality attributes.
Bupivacaine
Encapsulation efficiency
Liposome
Morphology
Particle size
QbD
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
01 Apr 2021
01 Apr 2021
Historique:
received:
17
11
2020
revised:
05
01
2021
accepted:
31
01
2021
pubmed:
6
2
2021
medline:
22
6
2021
entrez:
5
2
2021
Statut:
ppublish
Résumé
This study extends QbD principles to liposomal products containing a hydrophilic active pharmaceutical ingredient (API). The feasibility and advantages of the QbD concept for multivesicular liposome-based systems were demonstrated. We selected the local anesthetic drug bupivacaine as a model compound. Desired properties for three critical attributes of multivesicular liposome drug products, namely, the particle size, morphology, and drug encapsulation efficiency, were defined and evaluated. The liposome preparation process significantly affected both the liposome particle size and drug encapsulation efficiency. In this study, the effects of material attributes and processing parameters during the preparation of liposomes were studied in detail using a microscope and particle size analyzer. We used risk assessment to monitor several factors that substantially affect the encapsulation rate and particle size.
Identifiants
pubmed: 33545281
pii: S0378-5173(21)00139-3
doi: 10.1016/j.ijpharm.2021.120335
pii:
doi:
Substances chimiques
Liposomes
0
Bupivacaine
Y8335394RO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
120335Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.